Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07359664 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

OCTA in Cardiovascular Disease and Healthy Controls

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
University of Erlangen-Nürnberg Medical School
56 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Type 2 Diabetes
2,231 trials monitored
See 111 trials at risk
and 3 more diseases
This prospective clinical study will involve the non-invasive assessment of retinal vessels using OCTA (Cirrus OCT 6000 AngioPlex) and scanning laser Doppler flowmetry (SLDF) in patients with cardiovascular disease and healthy individuals. The study will be conducted at the Clinical Research Centre (CRC), Department of Nephrology and Hypertension at the University of Erlangen-Nuremberg.
Trial Details
NCT Number NCT07359664
Lead Sponsor University of Erlangen-Nürnberg Medical School
Collaborators: German Diabetes Association
Conditions
(from sponsor)		 Patients With Cardiovascular Disease, Healthy Participants
Related terms Diabetes Mellitus, Type 2, Heart Failure, Hypertension, Renal Insufficiency, Chronic
Enrollment 64 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov